Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success
Update: 2025-07-01
Description
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Arsalan Arif, founder of Endpoints News, for a wide-ranging conversation on the business of biotech. From his early days bootstrapping a media company to Endpoints’ recent partnership with the Financial Times, Arsalan shares his journey and reflections on what it takes to build trust in an evolving industry.
Together, they unpack today’s cell and gene therapy landscape, where clinical success alone isn’t enough. Arsalan offers his perspective on investor sentiment, why scaling remains the biggest challenge in CGT, and how economic models, not efficacy, will shape the next chapter of growth.
Learn more about Arsalan: https://www.linkedin.com/in/arsalanarif/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
